4-(3-chlorophenyl)-N-[4-[[3-(1H-pyrrolo[2,3-b]pyridin-4-yl)-2-pyridinyl]oxy]phenyl]phthalazin-1-amine
C32H21ClN6O — CID 66731761
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-(3-chlorophenyl)-N-[4-[[3-(1H-pyrrolo[2,3-b]pyridin-4-yl)-2-pyridinyl]oxy]phenyl]phthalazin-1-amine
4-(3-chlorophenyl)-N-[4-[[3-(1H-pyrrolo[2,3-b]pyridin-4-yl)-2-pyridinyl]oxy]phenyl]phthalazin-1-amine (PubChem CID 66731761) has the molecular formula C32H21ClN6O and a molecular weight of 541.01 g/mol. Its IUPAC name is 4-(3-chlorophenyl)-N-[4-[[3-(1H-pyrrolo[2,3-b]pyridin-4-yl)-2-pyridinyl]oxy]phenyl]phthalazin-1-amine.
Molecular Properties
| Compound Name | 4-(3-chlorophenyl)-N-[4-[[3-(1H-pyrrolo[2,3-b]pyridin-4-yl)-2-pyridinyl]oxy]phenyl]phthalazin-1-amine |
|---|---|
| PubChem CID | 66731761 |
| Molecular Formula | C32H21ClN6O |
| Molecular Weight | 541.01 g/mol |
| Exact Mass | 540.15 |
| IUPAC Name | 4-(3-chlorophenyl)-N-[4-[[3-(1H-pyrrolo[2,3-b]pyridin-4-yl)-2-pyridinyl]oxy]phenyl]phthalazin-1-amine |
| SMILES | Clc1cccc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc5[nH]ccc45)cc3)c3ccccc23)c1 |
| InChI | InChI=1S/C32H21ClN6O/c33-21-6-3-5-20(19-21)29-25-7-1-2-8-26(25)31(39-38-29)37-22-10-12-23(13-11-22)40-32-28(9-4-16-36-32)24-14-17-34-30-27(24)15-18-35-30/h1-19H,(H,34,35)(H,37,39) |
| InChIKey | QUXAUASPPDKBCO-UHFFFAOYSA-N |
| XLogP | 8.42 |
| TPSA | 88.61 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 40 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 541.01 |
| LogP ≤ 5 | 8.42 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 66731761 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.